VYNE THERAPEUTICS INC (VYNE) Stock Cash Flow
USA - NASDAQ:VYNE - US92941V3087 - Common Stock
0.352 USD
+0 (+1.03%)
0.352 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.55M | -39.83M | -28.45M | -23.21M | -73.33M | |||
| Depreciation Amortization | N/A | 0.00 | 0.00 | 70.00K | 110.00K | |||
| Change In Working Capital | -2.38M | 5.00M | 60.00K | 2.28M | 4.78M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 2.39M | |||
| Other non cash items | 1.13M | 860.00K | 3.05M | -8.34M | 12.08M | |||
| OPERATING CASH FLOW | -40.00M | -34.00M | -25.00M | -29.20M | -56.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -120.00K | N/A | N/A | 0.00 | |||
| Other Investing Activity | 33.00M | 23.00M | -57.00M | 15.67M | 1.03M | |||
| INVESTING CASH FLOW | 33.00M | 23.00M | -57.00M | 15.67M | 1.03M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | -36.43M | |||
| Stock Issued/Repurchased | -250.00K | -140.00K | 82.00M | 1.65M | 76.50M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -290.00K | |||
| FINANCING CASH FLOW | -250.00K | -140.00K | 82.00M | 1.65M | 39.78M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -7.25M | -11.14M | 0.00 | -11.88M | -15.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -40.00M | -34.00M | -25.00M | -29.20M | -56.37M | |||
| Capital Expenditure | N/A | -120.00K | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -40.12M | -34.12M | -25.00M | -29.20M | -56.37M | |||
All data in USD